154 related articles for article (PubMed ID: 17431766)
1. Two-stage case-control study of common ATM gene variants in relation to breast cancer risk.
Ye C; Dai Q; Lu W; Cai Q; Zheng Y; Shu XO; Gu K; Gao YT; Zheng W
Breast Cancer Res Treat; 2007 Nov; 106(1):121-6. PubMed ID: 17431766
[TBL] [Abstract][Full Text] [Related]
2. Association between ATM polymorphisms and cancer risk: a meta-analysis.
Shen L; Yin ZH; Wan Y; Zhang Y; Li K; Zhou BS
Mol Biol Rep; 2012 May; 39(5):5719-25. PubMed ID: 22203481
[TBL] [Abstract][Full Text] [Related]
3. The association between ATM D1853N polymorphism and breast cancer susceptibility: a meta-analysis.
Gao LB; Pan XM; Sun H; Wang X; Rao L; Li LJ; Liang WB; Lv ML; Yang WZ; Zhang L
J Exp Clin Cancer Res; 2010 Aug; 29(1):117. PubMed ID: 20799949
[TBL] [Abstract][Full Text] [Related]
4. Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility.
Johnson N; Fletcher O; Palles C; Rudd M; Webb E; Sellick G; dos Santos Silva I; McCormack V; Gibson L; Fraser A; Leonard A; Gilham C; Tavtigian SV; Ashworth A; Houlston R; Peto J
Hum Mol Genet; 2007 May; 16(9):1051-7. PubMed ID: 17341484
[TBL] [Abstract][Full Text] [Related]
5. Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls.
Fletcher O; Johnson N; dos Santos Silva I; Orr N; Ashworth A; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Burwinkel B; Bartram CR; Meindl A; Schmutzler RK; Cox A; Brock I; Elliott G; Reed MW; Southey MC; Smith L; Spurdle AB; Hopper JL; Couch FJ; Olson JE; Wang X; Fredericksen Z; Schürmann P; Waltes R; Bremer M; Dörk T; Devilee P; van Asperen CJ; Tollenaar RA; Seynaeve C; Hall P; Czene K; Humphreys K; Liu J; Ahmed S; Dunning AM; Maranian M; Pharoah PD; Chenevix-Trench G; ; ; Beesley J; Bogdanova NV; Antonenkova NN; Zalutsky IV; Anton-Culver H; Ziogas A; Brauch H; Ko YD; Hamann U; ; Fasching PA; Strick R; Ekici AB; Beckmann MW; Giles GG; Severi G; Baglietto L; English DR; Milne RL; Benítez J; Arias JI; Pita G; Nordestgaard BG; Bojesen SE; Flyger H; Kang D; Yoo KY; Noh DY; Mannermaa A; Kataja V; Kosma VM; García-Closas M; Chanock S; Lissowska J; Brinton LA; Chang-Claude J; Wang-Gohrke S; Broeks A; Schmidt MK; van Leeuwen FE; Van't Veer LJ; Margolin S; Lindblom A; Humphreys MK; Morrison J; Platte R; Easton DF; Peto J;
Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2143-51. PubMed ID: 20826828
[TBL] [Abstract][Full Text] [Related]
6. Screening for ATM sequence alterations in African-American women diagnosed with breast cancer.
Hirsch AE; Atencio DP; Rosenstein BS
Breast Cancer Res Treat; 2008 Jan; 107(1):139-44. PubMed ID: 17333338
[TBL] [Abstract][Full Text] [Related]
7. Rare variants in the ATM gene and risk of breast cancer.
Goldgar DE; Healey S; Dowty JG; Da Silva L; Chen X; Spurdle AB; Terry MB; Daly MJ; Buys SM; Southey MC; Andrulis I; John EM; ; ; Khanna KK; Hopper JL; Oefner PJ; Lakhani S; Chenevix-Trench G
Breast Cancer Res; 2011 Jul; 13(4):R73. PubMed ID: 21787400
[TBL] [Abstract][Full Text] [Related]
8. Population-based estimates of breast cancer risks associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Family Registry.
Bernstein JL; Teraoka S; Southey MC; Jenkins MA; Andrulis IL; Knight JA; John EM; Lapinski R; Wolitzer AL; Whittemore AS; West D; Seminara D; Olson ER; Spurdle AB; Chenevix-Trench G; Giles GG; Hopper JL; Concannon P
Hum Mutat; 2006 Nov; 27(11):1122-8. PubMed ID: 16958054
[TBL] [Abstract][Full Text] [Related]
9. Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study.
Bernstein JL; Haile RW; Stovall M; Boice JD; Shore RE; Langholz B; Thomas DC; Bernstein L; Lynch CF; Olsen JH; Malone KE; Mellemkjaer L; Borresen-Dale AL; Rosenstein BS; Teraoka SN; Diep AT; Smith SA; Capanu M; Reiner AS; Liang X; Gatti RA; Concannon P;
J Natl Cancer Inst; 2010 Apr; 102(7):475-83. PubMed ID: 20305132
[TBL] [Abstract][Full Text] [Related]
10. Single nucleotide polymorphism D1853N of the ATM gene may alter the risk for breast cancer.
Schrauder M; Frank S; Strissel PL; Lux MP; Bani MR; Rauh C; Sieber CC; Heusinger K; Hartmann A; Schulz-Wendtland R; Strick R; Beckmann MW; Fasching PA
J Cancer Res Clin Oncol; 2008 Aug; 134(8):873-82. PubMed ID: 18264724
[TBL] [Abstract][Full Text] [Related]
11. Association between ataxia telangiectasia mutated gene polymorphisms and breast cancer in Taiwanese females.
Wang HC; Chang WS; Tsai RY; Tsai CW; Liu LC; Su CH; Cheng HN; Tsou YA; Sun SS; Lin CC; Bau DT
Anticancer Res; 2010 Dec; 30(12):5217-21. PubMed ID: 21187516
[TBL] [Abstract][Full Text] [Related]
12. ATM haplotypes and breast cancer risk in Jewish high-risk women.
Koren M; Kimmel G; Ben-Asher E; Gal I; Papa MZ; Beckmann JS; Lancet D; Shamir R; Friedman E
Br J Cancer; 2006 May; 94(10):1537-43. PubMed ID: 16622469
[TBL] [Abstract][Full Text] [Related]
13. ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles.
Renwick A; Thompson D; Seal S; Kelly P; Chagtai T; Ahmed M; North B; Jayatilake H; Barfoot R; Spanova K; McGuffog L; Evans DG; Eccles D; ; Easton DF; Stratton MR; Rahman N
Nat Genet; 2006 Aug; 38(8):873-5. PubMed ID: 16832357
[TBL] [Abstract][Full Text] [Related]
14. On the proposed association of the ATM variants 5557G>A and IVS38-8T>C and bilateral breast cancer.
Langholz B; Bernstein JL; Bernstein L; Olsen JH; Børresen-Dale AL; Rosenstein BS; Gatti RA; ; Concannon P
Int J Cancer; 2006 Aug; 119(3):724-5. PubMed ID: 16496408
[No Abstract] [Full Text] [Related]
15. Comprehensive analysis of the ATM, CHEK2 and ERBB2 genes in relation to breast tumour characteristics and survival: a population-based case-control and follow-up study.
Einarsdóttir K; Rosenberg LU; Humphreys K; Bonnard C; Palmgren J; Li Y; Li Y; Chia KS; Liu ET; Hall P; Liu J; Wedrén S
Breast Cancer Res; 2006; 8(6):R67. PubMed ID: 17132159
[TBL] [Abstract][Full Text] [Related]
16. Association of common ATM variants with familial breast cancer in a South American population.
González-Hormazábal P; Bravo T; Blanco R; Valenzuela CY; Gómez F; Waugh E; Peralta O; Ortuzar W; Reyes JM; Jara L
BMC Cancer; 2008 Apr; 8():117. PubMed ID: 18433505
[TBL] [Abstract][Full Text] [Related]
17. Importance of ATM gene as a susceptible trait: predisposition role of D1853N polymorphism in breast cancer.
Mehdipour P; Mahdavi M; Mohammadi-Asl J; Atri M
Med Oncol; 2011 Sep; 28(3):733-7. PubMed ID: 20396981
[TBL] [Abstract][Full Text] [Related]
18. Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk.
Baynes C; Healey CS; Pooley KA; Scollen S; Luben RN; Thompson DJ; Pharoah PD; Easton DF; Ponder BA; Dunning AM;
Breast Cancer Res; 2007; 9(2):R27. PubMed ID: 17428325
[TBL] [Abstract][Full Text] [Related]
19. Common ataxia telangiectasia mutated haplotypes and risk of breast cancer: a nested case-control study.
Tamimi RM; Hankinson SE; Spiegelman D; Kraft P; Colditz GA; Hunter DJ
Breast Cancer Res; 2004; 6(4):R416-22. PubMed ID: 15217510
[TBL] [Abstract][Full Text] [Related]
20. Functional polymorphism rs189037 in the promoter region of ATM gene is associated with angiographically characterized coronary stenosis.
Li S; Zhang L; Chen T; Tian B; Deng X; Zhao Z; Yuan P; Dong B; Zhang Y; Mo X
Atherosclerosis; 2011 Dec; 219(2):694-7. PubMed ID: 21937043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
